The combination may result in more severe or prolonged gastrointestinal symptoms, potentially leading to dehydration, electrolyte imbalances, or nutritional deficiencies if food intake becomes severely restricted
Why the slow escalation matters Semaglutide activates GLP-1 receptors in the gut, pancreas, and brain
Provides continuous medical and nutritionist support throughout the treatment journey
requires clinical setting, higher cost, time-intensive
1-4 PIONEER 3: In a double-blind, double-dummy trial with a primary endpoint of mean change in A1C from baseline to Week 26, 1864 adult patients with type 2 diabetes receiving metformin alone or metformin with a sulfonylurea were randomized to semaglutide tablets 14 mg (n=465), 7 mg (n=466), 3 mg (n=466), or Januvia 100 mg (n=467), all once daily